Vaccination and its social and behavioural drivers in children with disability in Fiji Read more about Vaccination and its social and behavioural drivers in children with disability in Fiji16 views
Short term safety profile of respiratory syncytial virus vaccine in adults aged ≥ 60 years in Australia Read more about Short term safety profile of respiratory syncytial virus vaccine in adults aged ≥ 60 years in Australia9 views
Impact of Australia's No Jab, No Pay policy on vaccination uptake - a before-after study in two national birth cohorts Read more about Impact of Australia's No Jab, No Pay policy on vaccination uptake - a before-after study in two national birth cohorts31 views
Australian parents' experiences with adolescent age-based vaccinations during the COVID-19 pandemic Read more about Australian parents' experiences with adolescent age-based vaccinations during the COVID-19 pandemic21 views
Evaluation of the Queensland JEV vaccine program response to the 2022 Australian outbreak Read more about Evaluation of the Queensland JEV vaccine program response to the 2022 Australian outbreak7 views
Strategies to address COVID-19 vaccine hesitancy in First Nations peoples: a systematic review Read more about Strategies to address COVID-19 vaccine hesitancy in First Nations peoples: a systematic review50 views
ATAGI targeted review 2023: vaccination for preventing influenza in Australia Read more about ATAGI targeted review 2023: vaccination for preventing influenza in Australia66 views
Developing a research network of early warning systems for infectious diseases transmission between China and Australia Read more about Developing a research network of early warning systems for infectious diseases transmission between China and Australia21 views
Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross-sectional study Read more about Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross-sectional study19 views
The seroprevalence of antibodies to Japanese encephalitis virus in five New South Wales towns at high risk of infection, 2022: a cross-sectional serosurvey Read more about The seroprevalence of antibodies to Japanese encephalitis virus in five New South Wales towns at high risk of infection, 2022: a cross-sectional serosurvey10 views
